coteauBeta Get App
ASTS

ASTS

AST SpaceMobile, Inc.
$40.66
-8.55% Oct 16 close
Technology Compare
-58%-33%-9%+15%+39%Oct 2025Oct 2026Apr 2026
ASTSSPY
1W
-20.2%
1M
-31.4%
3M
-29.7%
6M
-52.5%
YTD
-44.0%
1Y
-54.6%

Live chart

Loading live chart…

What they do

AST SpaceMobile, Inc. designs and develops the constellation of BlueBird satellites in the United States. The company provides a cellular broadband network in space to be accessible directly by smartphones for commercial use and other applications, as well as for government use. Its SpaceMobile service provides cellular broadband services to end-users who are out of terrestrial cellular coverage.

Technology · Communication Equipment

For information only · Important disclosures

Grades vs sector

No sector grades for ASTS yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
Should You Sell Your AST SpaceMobile Stock Now?
Trefis · 53m ago
Stock Market Today, Oct. 21: Space Exploration Technologies Surges on Q3 Earnings Beat
Nasdaq · 1h ago
SpaceX Jumps 8% on Q3 Revenue Beat as Musk Backs Tesla Merger Idea; Rocket Lab and AST SpaceMobile Edge Higher
24/7 Wall St. · 9h ago
AST SpaceMobile, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ASTS
PR Newswire · 22h ago
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in AST SpaceMobile, Inc. to Contact Law Firm
PR Newswire · 22h ago

Key stats

Market value$16.0B
P/E (next 12 months, estimated)-32.0
52-week range$39.02 – $133.86
Revenue growth (latest quarter vs a year ago)+2626.6%
Dividend yieldNo dividend
Analyst consensusHold (12)
Average analyst price target$74.28 (+83%)
Valuation and fundamentals

Valuation & fundamentals

Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
•Piotroski F-score4/9
•Altman Z3.0 (grey)
▲Net debt / EBITDA-25.1x
▲Analyst target+83% (12 analysts)

Discounted cash flow

Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 2.71 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $-1.29 vs trailing $-2.13. Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin
0.0%
Operating margin
-2.1%
FCF margin
-1420.7%
Net margin
-536.7%
Return on equity
-12375.2%
Return on invested capital
–
Net debt / EBITDA
-25.1×
Current ratio
13.1×
Interest cover
-0.0×
Cash conversion (OCF/NI)
–
Piotroski F-score 4/9 · last two fiscal years
✗ Positive net income✗ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✗ Gross margin improved✓ Asset turnover improved

Altman Z-score 3.0 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target
$74
+83%
Analysts
12
Hold
Range
$42–$108
low – high
● price · ◆ mean target

Annual history

FYRevenueNet incomeFree cash flow
2025$70.9M$-341.9M$-1.1B
2024$4.4M$-300.1M$-300.3M
2023$0$-87.6M$-267.7M
2022$13.8M$-31.6M$-213.7M
2021$12.4M$-30.6M$-95.2M
2020$6.0M$-52.0M$-30.9M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +72.5%.

Earnings

Next report: 2026-11-09 · during market · EPS est -0.45
24-1125-0325-0525-0825-1126-0326-0526-08-1.100.00
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-10-0.33-0.77-132.0%
2026-05-11-0.20-0.66-233.7%
2026-03-02-0.20-0.26-30.0%
2025-11-10-0.26-0.45-74.4%
2025-08-11-0.22-0.41-89.2%
2025-05-12-0.22-0.20+11.1%
2025-03-03-0.18-0.12+29.2%
2024-11-14-0.20-1.10-443.1%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$31.5M+2626.6%
2026-03-31$14.7M–
2025-12-31$54.3M–
2025-09-30$14.7M–
2025-06-30$1.2M–
Analyst actions
Piper Sandler
2026-10-13 · down
Overweight → Neutral
PT $54
Deutsche Bank
2026-10-12 · up
Hold → Buy
PT $93
B. Riley Securities
2026-10-02 · down
Buy → Neutral
PT $65
Berenberg
2026-09-02 · init
→ Buy
PT $92
UBS
2026-08-11 · main
Neutral → Neutral
PT $78
Piper Sandler
2026-08-11 · main
Overweight → Overweight
PT $98

Stats refreshed 2026-10-21 12:07:37 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026